• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioAtla, Inc. - Common Stock (NQ:BCAB)

0.3082 -0.0018 (-0.58%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about BioAtla, Inc. - Common Stock

News headline image
BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody
September 23, 2024
From Context Therapeutics Inc.
Via GlobeNewswire
News headline image
BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 20, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event
December 05, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla to Participate in the JMP Securities Hematology and Oncology Summit
November 30, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC
November 28, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla Reports Third Quarter 2023 Financial Results and Highlights Recent Progress
November 07, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla to Participate in the Jefferies London Healthcare Conference
November 06, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla’s Jay M. Short, Ph.D., Selected for The Explorers Club Lowell Thomas Award
October 12, 2023
Award recognizes Dr. Short’s contribution to science innovation 
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla Provides Guidance on Near-Term Milestones and Plans to Announce Third Quarter 2023 Financial Results and Business Update on November 7, 2023
October 10, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 06, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla to Participate in Upcoming Investor Conferences in August
August 03, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla Reports Second Quarter 2023 Financial Results and Highlights Recent Progress
August 01, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla to Announce Second Quarter 2023 Financial Results and Provide Business Highlights on August 1, 2023
July 25, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla Added to Membership of U.S. Small-Cap Russell 2000® Index
June 26, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla to Participate in the Jefferies Healthcare Conference
May 31, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla Reports First Quarter 2023 Financial Results and Highlights Recent Progress
May 11, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla to Participate in the JMP Securities Life Sciences Conference
May 08, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla to Announce First Quarter 2023 Financial Results and Provide Business Highlights on May 11, 2023
May 04, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Progress
March 23, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla to Announce Fourth Quarter and Full-Year 2022 Financial Results and Provide Business Highlights
March 16, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla Announces Change in Executive Leadership
February 27, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3182, a CAB-EpCAMxCAB-CD3 Bispecific T-Cell Engager for the Treatment of Advanced Adenocarcinoma
February 23, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla Provides Clinical Program Updates and Upcoming 2023 Milestones
January 10, 2023
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla to Participate in the 41st Annual J.P. Morgan Healthcare Conference
December 22, 2022
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla to Participate in the Jefferies London Healthcare Conference
November 08, 2022
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla Announces $65 Million Underwritten Offering of its Common Stock
November 04, 2022
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla Reports Third Quarter 2022 Financial Results and Highlights Recent Progress
November 03, 2022
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla to Announce Third Quarter 2022 Financial Results and Provide Business Highlights on November 3, 2022
October 27, 2022
From BioAtla, Inc.
Via GlobeNewswire
News headline image
BioAtla to Announce Second Quarter 2022 Financial Results and Provide Business Highlights on August 9, 2022
August 02, 2022
From BioAtla, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap